Lawmakers Grill CFTC Chair Over Hyperliquid, Prediction Markets
Lawmakers pressed CFTC Chair Selig at a Capitol Hill hearing over oversight of prediction markets, the Hyperliquid trading platform and the agency’s staffing shortages.
At a recent Capitol Hill oversight hearing, lawmakers questioned Commodity Futures Trading Commission Chair Selig about the agency’s approach to prediction markets, regulatory gaps around the Hyperliquid trading platform and persistent staffing shortfalls.
Members of Congress asked how the CFTC decides when a prediction market falls under the Commodity Exchange Act and when other regulators should intervene. Lawmakers focused on platforms that combine novel contract terms, token-based settlement and leverage, raising concerns about where legal responsibility lies and whether traders face unfair practices or systemic risk.
Questions about Hyperliquid centered on whether the platform is registered or licensed to offer derivatives or other tradable contracts, how customer funds are protected, and whether the agency can detect manipulation or wash trading on such venues. Committee members sought clarity on the agency’s authority to pursue investigations or make referrals to other law enforcement bodies in cross-jurisdictional cases.
Selig acknowledged the regulatory complexity created by new trading models and said the agency is reviewing how to apply existing statutes. He described efforts to coordinate with other federal agencies and indicated the CFTC is considering whether targeted rulemaking will be necessary, without committing to immediate new rules.
On staffing, Selig described active recruitment for technologists, data analysts and enforcement attorneys and noted the agency competes with higher-paying private firms for talent. He reported use of temporary hires and contractors to fill critical roles and said long-term capacity depends on sustained funding and congressional support.
Lawmakers pressed for specific actions: more frequent public guidance on how the CFTC interprets jurisdiction over event-based contracts, faster resolution of registration questions for novel trading platforms and stronger surveillance of venues that combine crypto assets with derivatives-like products. Several members asked whether the agency could open targeted investigations into Hyperliquid if evidence of rule violations emerges.
Selig outlined steps the agency is taking to strengthen oversight, including increased data-sharing with other regulators, expanded technical training for staff and prioritizing enforcement resources toward platforms that pose the greatest risk to market integrity. He said the CFTC has been using enhanced monitoring tools and analytical techniques to detect suspicious trading patterns, but acknowledged gaps remain when platforms use offshored infrastructure or novel token mechanics.
Industry witnesses who testified separately urged regulators to provide clearer registration pathways for new platforms and stronger disclosure requirements for products that behave like derivatives. Lawmakers asked both industry witnesses and the CFTC for timelines and concrete milestones on guidance and potential rulemaking.
The CFTC has authority over many derivatives and commodity-linked instruments, but newer products that tie payouts to political outcomes, tokenized assets or decentralized trading systems raise legal and jurisdictional questions. Multiple regulators may assert authority depending on whether a product is a commodity, a security or a new crypto instrument, which can complicate enforcement and investor protections.
The hearing produced no immediate regulatory changes. Lawmakers indicated they will continue oversight and expect the CFTC to provide more detailed plans on prediction markets, the status of platforms such as Hyperliquid and the agency’s staffing needs.
The content on The Coinomist is for informational purposes only and should not be interpreted as financial advice. While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, or reliability of any content. Neither we accept liability for any errors or omissions in the information provided or for any financial losses incurred as a result of relying on this information. Actions based on this content are at your own risk. Always do your own research and consult a professional. See our Terms, Privacy Policy, and Disclaimers for more details.








